MedTrace Logo

Study of the Analytical Performance of ALLEGRO™ Instrument

NCT04035044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-07-29

No results posted yet for this study

Summary

A new analyser has been developed (Allegro™) which allows the tests to be undertaken at the clinic, with the results available in a few minutes. This means that patients can get immediate feedback and that the doctors/nurses can adjust treatment before the patient leaves the clinic. It is obviously important that this analyser performs to a similar degree of accuracy to the laboratory analyses.

Conditions

Sponsors & Collaborators

  • C-TRIC

    collaborator UNKNOWN

  • Nova Biomedical

    lead INDUSTRY

Principal Investigators

  • Bogdan Milojkovic, PhD · Nova Biomedical

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-05-31
Completion
2018-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04035044 on ClinicalTrials.gov